Background: Lung transplantation is a recognised treatment for end-stage lung disease due to bronchiectasis. Non-cystic fibrosis (CF) bronchiectasis and CF are often combined into one cohort; however, outcomes for non-CF bronchiectasis patients vary between centres, and in comparison with those for CF.
Aims: To compare lung transplantation mortality and morbidity of bronchiectasis (non-CF) patients with those with CF and other indications.